The Global Biopharma Resilience Index

Cytiva’s Global Biopharma Resilience Index – based on a survey of more than 1,000 senior biopharma executives – takes a holistic look at the industry across five key pillars at a time when its health is vital. Fresh data shows there is work to be done to secure its future.

Emmanuel will speak about the challenges in the industry and what we can do to meet them.

EMMANUEL LIGNER | President and Chief Executive Officer | Cytiva